NCT03496766 2025-03-05
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Spanish Lung Cancer Group
Phase 2 Terminated
Clinical Trials
4 trialsNCT00847223 2018-08-23
Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma
Lymphoma Study Association
Phase 2 Terminated
NCT00361088 2013-11-25
A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated
NCT00210028 2006-11-14
Study Assessing Efficacy of ZARNESTRAâ„¢ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
Institut Claudius Regaud
Phase 2 Terminated